http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019076487-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ae2fbbd95296ad63c505160cc9be30f |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-741 |
filingDate | 2018-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e8f4078f3347b8cfedadc39c068d24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a16cffbb96b6a21e358f1c88f235f2f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7da7b182e628e8ac7e62855aa6babea0 |
publicationDate | 2019-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2019076487-A1 |
titleOfInvention | Anaeroplasmatales for use in the treatment or prevention of an inflammatory disorder of the digestive system |
abstract | A composition including one or more bacteria of the order Anaeroplasmatales for use as a medicament in methods of treatment or prevention of an inflammatory disorder of the digestive system. Preferred embodiments of the invention relate to methods employing Anaeroplasma in the treatment or prevention of an inflammatory disorder of the digestive system. Preferably, the inflammatory disorders of the digestive system are inflammatory bowel disease, colitis, Crohn's disease (CD) or ulcerative colitis (UC). Furthermore, it is preferable that the composition of the present invention causes increased TGF-β and/or IgA production in the intestine or other component of the digestive tract compared to subjects who have not received administration of the composition. |
priorityDate | 2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.